Pregnancy: In non-clinical reproductive toxicity studies there were foetal developmental effects, which are considered to be due to the pharmacological action of felodipine.
Breastfeeding: Felodipine has been detected in breast milk, and due to insufficient data on potential effect on the infant, treatment is not recommended during breastfeeding.
Fertility: In a nonclinical reproductive study in the rat, there were effects on foetal development but no effect on fertility at doses approximating to therapeutic.